Compare FHTX & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FHTX | SEVN |
|---|---|---|
| Founded | 2015 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 173.4M | 167.9M |
| IPO Year | 2020 | 2008 |
| Metric | FHTX | SEVN |
|---|---|---|
| Price | $1.89 | $6.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 5 |
| Target Price | $4.17 | ★ $9.55 |
| AVG Volume (30 Days) | ★ 1.1M | 178.7K |
| Earning Date | 11-04-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 16.21% |
| EPS Growth | ★ 25.32 | N/A |
| EPS | N/A | ★ 0.19 |
| Revenue | ★ $30,909,000.00 | $29,383,000.00 |
| Revenue This Year | N/A | $18.67 |
| Revenue Next Year | $15.98 | $12.98 |
| P/E Ratio | ★ N/A | $36.37 |
| Revenue Growth | ★ 36.75 | N/A |
| 52 Week Low | $1.79 | $6.70 |
| 52 Week High | $7.61 | $10.90 |
| Indicator | FHTX | SEVN |
|---|---|---|
| Relative Strength Index (RSI) | 15.48 | 37.63 |
| Support Level | $1.79 | N/A |
| Resistance Level | $5.35 | $7.84 |
| Average True Range (ATR) | 0.27 | 0.16 |
| MACD | -0.06 | 0.00 |
| Stochastic Oscillator | 5.10 | 33.33 |
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in originating and investing in floating-rate first mortgage loans secured by middle-market and transitional commercial real estate. Its primary objective is to balance capital preservation with the generation of risk-adjusted returns. The company operates in one business segment: originating and investing in floating-rate first mortgage loans secured by CRE properties.